Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update

Aethlon Medical, Inc. (NASDAQ:AEMD) was the recipient of a large decline in short interest in the month of September. As of September 15th, there was short interest totalling 182,100 shares, a decline of 20.1% from the August 31st total of 227,800 shares. Based on an average trading volume of 2,000,000 shares, the short-interest ratio is currently 0.1 days.

Aethlon Medical Stock Performance

Shares of AEMD opened at $0.47 on Friday. Aethlon Medical has a 1 year low of $0.24 and a 1 year high of $2.40. The company has a market cap of $6.59 million, a price-to-earnings ratio of -0.10 and a beta of 1.72. The firm has a fifty day moving average of $0.39 and a 200-day moving average of $0.78.

Aethlon Medical (NASDAQ:AEMD) last released its quarterly earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.10. During the same quarter last year, the business posted ($1.30) EPS. Analysts predict that Aethlon Medical will post -1.1 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on AEMD. StockNews.com initiated coverage on Aethlon Medical in a report on Sunday. They issued a “sell” rating on the stock. HC Wainwright reduced their price objective on shares of Aethlon Medical from $10.00 to $7.00 and set a “buy” rating for the company in a research report on Monday, June 24th.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.